astellas pharma inc

Japan Approves World’s First Transdermal Beta-Blocker Patch

Toa Eiyo Ltd. has received manufacturing and marketing authorization in Japan for its transdermal Bisono® beta-blocker tape.

Amgen & Astellas Enter Into Japan Alliance

Amgen and Astellas Pharma Inc. today announced a strategic alliance to co-develop and co-commercialize new medicines in Japan.

Astellas, Ambryx Sign US$300 Million Antibody Drug Conjugate Deal

Astellas Pharma Inc. on Thursday entered into a collaboration with Ambrx Inc. for the discovery and development of novel antibody drug conjugates.

Astellas Pharma Releases Phase II Data For Leukemia Drug

Approximately 50 percent of FLT3-ITD positive AML patients achieved complete remission with Astellas Pharma's new investigational drug, according to Phase II data results.